Rays of hope for rare ovarian cancers A great fallacy of statistical method applied to clinical medicine is the assumption that one equals one. For example, the death of an 80 year old from ovarian cancer is sad-but not comparable to the loss of an 18 year old just flowering into full womanhood from what, for certification purposes, is the same disease. Avoidance of the former death would serve only to delay a few months or years the old lady's ultimate entry in the Registrar General's records, possibly transferring it to a coding less likely to be associated with a miserable demise. On the other hand, it would be a triumph if the death of the 18 year old, with its impact on the lives of family and friends, could be averted.
Ovarian cancers may be divided into two categories approximating to these age extremes. Most develop from the surface epithelium and occur in relatively senior women; a few arise from germinal epithelium and affect young women. Any progress in preventing deaths in this group would not be evident in the total mortality statistics; even if it were, the mere numbers would not disclose the true value of preventing these deaths.
The extensive classification of ovarian tumours proposed by the World Health Organisation has the daunting impact of a metropolitan telephone directory. At one time its use seemed rather an academic exercise of relevance only to pathologists devoting their lives to the subject-but this is no longer true. If each type of rare germ cell tumour is studied and managed individually, greatly improved results may be obtained. A recent report suggests that pessimistic attitudes about malignant teratomas and advanced dysgerminomas should be revised.' Thirteen of 18 patients (mean age 19 3 years) with metastatic malignant (immature) teratomas who received combination chemotherapy were in complete clinical and biochemical remission after a mean of 27-5 months off treatment. Three patients with advanced dysgerminomas were also in complete remission five, 14, and 33 months after stopping chemotherapy. Most metastatic germ cell tumours now seem curable provided that effective treatment is begun early. Eleven teratomas produced cx-fetoprotein or human chorionic gonadotrophin and six produced both. The one producing no marker proved fatal, as did three producing both, but high concentrations from the outset had indicated a poor prognosis. Pulsed chemotherapy was continued until complete clinical and biochemical remission had been maintained for 12 weeks. The initial pulses consisted of vincristine, methotrexate with folinic acid rescue, bleomycin, and cisplatin followed by VP 16-213 (etoposide), actinomycin D, and cyclophosphamide. A third regimen was dropped after evidence of resistance appeared. Cisplatin was omitted from the first regimen after achieving remission. All the patients with postpubertal teratomas were menstruating normally, so that presumably their fertility was reasonably good.
Endodermal sinus tumours produce o-fetoprotein and carry a high mortality. With combination chemotherapy and monitoring of ax-fetoprotein after unilateral salpingooophorectomy successful remission has been achieved2 and followed by pregnancy.3 4 Wiltshaw et al have recently reported complete remission with conservation of the uterus and one ovary in seven of eight cases.5 These cases emphasise that cure is not the only consideration with germ cell malignancy in girls. Dysgerminoma is the most common tumour and is very radiosensitive. Aggressive treatment can cure almost all stage I cases, but loss of ability to bear children may be an unnecessarily high price. Sixty seven of 72 patients with stage Ia pure dysgerminomas treated by unilateral salpingo-oophorectomy alone were alive and free from disease at five years.6 When the tumour was of mixed type the five year survival was only 250, which emphasises the importance of looking at "pure" tumour types. The conservative policy relies on the efficacy of radiation for dealing with recurrence. Chemotherapy has rarely been used with localised dysgerminomas because of the excellent results with radiotherapy; but if used judiciously it may achieve the same end with preservation of fertility.
Weinblatt and Ortega7 have reported successes and advocate giving chemotherapy initially for extensive dysgerminoma in childhood in the hope that if the tumour responds surgery may be unnecessary or can be less radical. De Palo et al, reviewing 56 pure dysgerminomas, describe four patients treated by conservative surgery and chemotherapy with survival at 60, 61, 77, and 89 months. 8 The most extensive staging procedures are necessary in these cases as is the opinion of an expert pathologist on the precise nature of the tumour. Then the aim is to achieve the maximum chance of cure with the minimum risk of sterilisation, giving any chemotherapy with optimal efficiency. Opinions vary on the referral of patients with cancer to specialist regional centres. Undoubtedly, however, young women with germ cell tumours should be dealt with where special skill exists, as are patients with trophoblastic neoplasia. There is a striking similarity between the advances made with chemotherapy in these cancers in young women and those achieved earlier with trophoblastic malignancy.
When chemotherapy achieves a cure with preservation of potential fertility, the likely outcome in terms of childbearing is obviously of great importance. Barber9 concluded that, though further studies are needed, the evidence justifies optimism. Though conception rates may be reduced, there is no evidence of any substantial increase in pregnancy wastage or fetal abnormality.
There are also opportunities for prophylaxis. Medical education sometimes seems to be pervaded by the spirit of the stick and the carrot. Continuing education in the United States exemplifies confusion about how to achieve the desired end-by awarding good conduct stars through schemes such as the physicians' recognition award, or by threatening various stripes for default. The JAMA report on continuing education has an enthusiastic account of what technology can do for informatics and, for the rest, a good many dull facts and sterile definitions. Two statements tell most of the story: "It has been difficult to document a positive correlation between a physician's participation in continuing medical education and improved patient care" and, "It is clearly evident that the trend towards mandatory continuing medical education has come to a halt."
The bland conclusion that "Continuing medical education in its various modes is a prerequisite for the competent practice of medicine" is a fair declaration of faith. What remains is not so much to prove it as to make it true, and if there are not more stimulating activities in this direction than are dreamt of in this report's philosophy, then there is something to be learnt from general practice in the United Kingdom. The key is the relation of continuing education to standards of practice-the integration of learning, and teaching with audit, so that continuing education becomes the means and the measure of improvement in the quality of medical care.
The There is little evidence of manpower planning at the postgraduate stage or of successful efforts to relate the numbers of training opportunities to the needs of the community. The generally passive approach is reflected in the comment, "The choice of location and the choice of specialty will undoubtedly be limited for many persons," and by the relative numbers of residency positions available-well over 9000 in surgery and urology, compared with under 2000 in anaesthesiology.
Residency training in emergency medicine is singled out as a new specialty, with programmes first accredited in 1982.
The general picture this report presents is one of activity and awareness of problems that remain. It is always difficult to write specifically about medical education while acknowledging its interrelation with service and manpower. The report describes, for instance, current policies and attitudes on acceptance into postgraduate training programmes for graduates from foreign medical schools and United States citizens who have graduated elsewhere, but it makes no comment on the extent to which these doctors become absorbed into the practising profession and what views there are about this. The complex relations between the various bodies concerned with the control of medical education, particularly at the postgraduate stage, are well described. The importance of the autonomy of the specialty boards is rightly emphasised, and the comment that "any attempt to politicise the boards should be resisted vigorously" is well made.
There are many other chords of sympathy between the American way of thinking and our own. It is a question of how to reconcile the separateness and independence of individual specialties, the maintenance of proper educational standards, and the right of the profession to self determination and self control with the need for a system which can meet the requirements of the community. JAMA pleads for a single organisation-the American Medical Association Council of Medical Education-to take the initiative in identifying and addressing the major issues in medical education. Identifying and addressing issues is not, however, the same as solving problems, because the problems ofmedical education interlock with those
